BDBM46535 (1Z)-1-(4-bromanylpyrazol-3-ylidene)-N-[(2-methylphenyl)methoxy]methanamine::(1Z)-1-(4-bromo-3-pyrazolylidene)-N-[(2-methylphenyl)methoxy]methanamine::(1Z)-1-(4-bromopyrazol-3-ylidene)-N-[(2-methylphenyl)methoxy]methanamine::4-bromo-1H-pyrazole-3-carbaldehyde O3-(2-methylbenzyl)oxime::MLS000861414::SMR000460198::[(Z)-(4-bromopyrazol-3-ylidene)methyl]-(2-methylbenzyl)oxy-amine::cid_16667390

SMILES O=C(c1ccc2c(c1)OCCN2c1ccccc1)N1CCCCC1

InChI Key InChIKey=MPLACVPYQFZLDY-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 46535   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 46535BDBM46535(US12577217, Example 1-18)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent